NCT04014101 SHR-1210 Plus Apatinib in Patients With Advanced-Stage Hepatocellular Carcinoma Status UNKNOWN Phase PHASE2
NCT04012021 EXplanted LIver and Ex-vivo Pancreatic Specimen Evaluation by 7 TESLA MRI Status UNKNOWN Phase NA
NCT04011033 Study of Adoptive Transfer of iNKT Cells Combined With TAE/TACE to Treat Unresectable HCC Status COMPLETED Phase PHASE2
NCT03998033 Study of ET140202 T Cells in Adults With Advanced Hepatocellular Carcinoma Status TERMINATED Phase PHASE1
NCT03996681 TACE Combined With Methylcantharidimide Tablets in the Treatment of Large and Unresectable Hepatocellular Carcinoma Status UNKNOWN Phase PHASE4
NCT03990974 Postoperative Antimicrobial Prophylaxis Versus Placebo for Infection Prevention in HCC After Liver Resection Status SUSPENDED Phase PHASE3
NCT03988998 Radiofrequency Ablation Plus Radiotherapy for Small Hepatocellular Carcinoma Status UNKNOWN Phase PHASE3
NCT03983954 Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer. Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03981848 Radiomics-based Non-invasive Classifier Research for HCC-related Liver Transplantation Status UNKNOWN Phase N/A
NCT03973112 A Clinical Study Evaluating the Use of HLX10 in Combination With HLX04 for the Treatment of Advanced Hepatocellular Carcinoma (HCC) Patients Status UNKNOWN Phase PHASE2
NCT03971747 AFP Specific T Cell Receptor Transduced T Cells Injection(C-TCR055) in Unresectable Hepatocellular Carcinoma Status UNKNOWN Phase PHASE1
NCT03970616 A Study of Tivozanib in Combination With Durvalumab in Subjects With Advanced Hepatocellular Carcinoma Status TERMINATED Phase PHASE1/PHASE2
NCT03969576 Drug-eluting Bead Transarterial Chemoembolisation (DEB-TACE) Versus (VS) Conventional Transarterial Chemoembolisation (cTACE) for Unresectable Hepatocellualr Carcinoma (HCC) Status UNKNOWN Phase NA
NCT03966209 Safety and Efficacy of PD-1 Inhibitors in Patients With Liver Transplant Status UNKNOWN Phase PHASE1
NCT03965546 ET 140202 -T Cell Combined With TAE or Sorafenib in the Treatment of Liver Cancer Status UNKNOWN Phase EARLY_PHASE1
NCT03963206 Cabozantinib toLERANCE Study in HepatoCellular Carcinoma (CLERANCE) Status COMPLETED Phase PHASE4